Communiqués Center Laboratories, Inc.

Actions

4123

TW0004123005

Cours en clôture Taipei Exchange Autres places de cotation 00:00:00 17/07/2024			Varia. 5j.	Varia. 1 janv.
56,4 ^TWD	+0,53 %		-1,23 %	+27,31 %

05/07	Center Laboratories, Inc. annonce une distribution en espèces provenant de l'excédent de capital, payable le 30 août 2024	CI
15/05	Center Laboratories, Inc. annonce la démission de Lin Shirley Yi-Hsien en tant qu'administrateur indépendant	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Center Laboratories : To announce the ex-rights and dividend record date and the closure period for the conversion of CB4 and CB5	11/08/22	PU
Center Laboratories : Amendment on the Company's 2021 Annual Report	10/08/22	PU
Center Laboratories : Announcement on the change of internal audit officer	27/07/22	PU
Center Laboratories : Announcement on the Company’s board resolution to the removal of non-compete restrictions on manager	27/07/22	PU
Center Laboratories : Announcement on the Company's board resolution to increase the investment on Mycenax Biotech Inc	27/07/22	PU
Center Laboratories : The Company cooperated with the Ministry of Justice Investigation Bureau's investigation as a third party.	14/07/22	PU
Center Laboratories : Announcement on changing the effective date of the merger between the Company and its subsidiary Bioengine Capital Inc.	29/06/22	PU
Center Laboratories : Correction made on the Company’s Consolidation Financial Report for the Q1 2022 filled to the Mops	08/06/22	PU
Center Laboratories : Announcement on the Company’s Board resolution to increase the investment on TOT Biopharm International Company Limited	31/05/22	PU
Center Laboratories : The Board of Directors approved to appoint the members of 5th Remuneration Committee	20/05/22	PU
Center Laboratories : To announce newly appoint members of the 2nd term of Audit Committee.	20/05/22	PU
Center Laboratories : The Company's 2022 Annual Shareholders' Meeting approved the release of non-competition restrictions on newly elected Directors	20/05/22	PU
Center Laboratories : Lin, Jung Chin is elected as Chairman by the Board of Directors	20/05/22	PU
Center Laboratories : Announcement of the appointment of representative by the newly elected institutional director	20/05/22	PU
Center Laboratories : To announce the major resolutions of 2022 Annual Shareholders' Meeting	20/05/22	PU
Center Laboratories : To announce Directors elected by 2022 Annual Shareholders’Meeting	20/05/22	PU
Center Laboratories : Explanation of the difference between the self -closing declarations of related party transactions and the audited review by CPA for the fourth quarter of 2021	13/04/22	PU
Center Laboratories : Announcement the Board of Directors resolved the merger of subsidiary, Bioengine Capital Inc.	07/04/22	PU
Center Laboratories : The Board resolved to convene 2022 Annual General Shareholders’Meeting (Agenda new added)	07/04/22	PU
Center Laboratories : Announcement on behalf of subsidiary, BioEngine Capital Inc, Merged with parent company.	07/04/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Center Laboratories, Inc.

Actions

4123

TW0004123005

Communiqués

Filtres